India's leading biopharma company, Biocon Limited on Thursday said that “It has received a Form 483 and two observations for its Small Molecules API...
The US Food and Drug Administration (USFDA) has issued a warning letter to Cipla's Goa manufacturing facility.
In a regulatory filing with Stock Exchange, the...
India's leading biopharma company Biocon on Saturday said that “It has received three observations for its insulin manufacturing facility in Malaysia from the United...